Abstract
Chemistry is the science of chemical reactions, the study of chemical properties, composition, and structure of a molecule. When the molecule under observation is of a biological origin (proteins, carbohydrates, lipids, or nucleic acids), the study of its chemical properties, reactions, and structure is known as biochemistry. Similarly, if the molecule or a biochemical under observation is radioactive, the science becomes radiochemistry or radio biochemistry. So, chemistry is the science which fuses these two diverse fields of applied sciences. Fusion of these two sciences on chemistry platform has enabled the development of various new radioactive formulations which are called as radiopharmaceuticals and are being used the world over for clinical as well as experimental purposes. For the successful development of radiopharmaceuticals, we require in-depth understanding of both biochemistry as well as radiochemistry. So, the present review article summarizes basic relevant details and experimental advances in both these sciences with regard to development of radiopharmaceuticals.
Similar content being viewed by others
References
What is Chemistry?. Chemweb.ucc.ie. Accessed 12 June 2011.
Theodore, L. B., Eugene Lemay, H., Edward Bursten, B., & Lemay, H. (1999). Chemistry: The central science (8th ed.). London: Prentice Hall.
Ben-Menahem Ari, (2009). Historical encyclopedia of natural and mathematical sciences (p. 2982). New York: Springer.
http://www.visionlearning.com/en/library/Chemistry/1/Chemical-Bonding/55.
Reilly, Michael. (2007). Mechanical force induces chemical reaction. Reilly: NewScientist.com News Service.
Mashaghi, A., & Katan, A. (2013). A physicist’s view of DNA. De Physicus, 24e(3), 59–61.
Schwochau Klaus, (2000). Technetium. Weinheim: Wiley-VCH.
Maruvada, P., Wang, W., Wagner, P. D., et al. (2005). Biomarkers in molecular medicine: Cancer detection and diagnosis. Bio-Techniques, 38, S9.
Gniazdowska, E., Koźmiński, P., Bańkowski, K., & Ochman, P. (2014). 99mTc-labeled vasopressin peptide as a radiopharmaceutical for small-cell lung cancer (SCLC) diagnosis. Journal of Medicinal Chemistry, 57(14), 5986.
Gann ting, Chih-hsienchang, & Hsin-ell wang, (2009). Cancer nanotargeted radiopharmaceuticals for tumor imaging and therapy. Anticancer Research, 29, 4107–4118.
Malhotra, A., Kumar, P., Sharma Sarika, & Dhawan, D. K. (2010). Macroaggregates(MAA) of albumin for lung imaging. Studies on better tissue to background ratio, on MAA stability and reuse after its preparation. Hellenic Journal of Nuclear Medicine, 13(3), 229–232.
Aloj, L., & Morelli, G. (2004). Design, synthesis and preclinical evaluation of radiolabel peptides for diagnosis and thepay. Current Pharmaceutical Design, 10, 3009–3031.
Giblin, M. F., Veerndra, B., & Smith, C. J. (2005). Radiometallation of receptor specific peptides for diagnosis and treatment of human cancer. In Vivo, 19, 73–79.
Eberle, A. N., Mild, G., & Frodevaux, S. (2004). Receptor mediated tumor targeting with radiopeptides. General concepts and methods: applications to somatostatin receptor expressing tumors. Journal of Receptors and Signal Transduction, 24, 319–455.
Qin, G. M., Zhang, Y. X., Cao, W., et al. (2005). Molecular imaging of atherosclerotic plaques with technetium-99m-labeled antisense oligonucleotides. European Journal of Nuclear Medicine and Molecular Imaging, 32, 6–14.
Borkowski, S., & Dinkelgborg, L. (2006). Aptamers for in vivo imaging. In S(. Klussmann (Ed.), The aptamer handbook. Weinheim: Wiley.
Callhahan, R. J., Dragotakes, S. C. M., Barrow, S. A., et al. (2001). A phase I clinical trial fo the DAT ligand Tc -99mO(15)O5T. Journal of Nuclear Medicine, 42, 1125.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zhang, X., Zhang, Y. & Malhotra, A. Radiolabeling in Biology. Cell Biochem Biophys 72, 1–10 (2015). https://doi.org/10.1007/s12013-014-0416-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12013-014-0416-4